Available to sourceHuman Prescription DrugGastrointestinal

Sodium Chloride

2.5 meq/mL · Injection Solution Concentrate

By Fresenius Kabi USA, LLC

NDC: 63323-090
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: ANDA

Package sizes

25 VIAL, PLASTIC in 1 TRAY (63323-090-20) / 20 mL in 1 VIAL, PLASTIC (63323-090-02)NDC 63323-090-20Available to order
25 VIAL, PLASTIC in 1 TRAY (63323-090-40) / 40 mL in 1 VIAL, PLASTIC (63323-090-04)NDC 63323-090-40Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.